INTREPID

INTREPID project aims at developing a multi-sensor wearable system for the treatment of phobias and situational anxiety. INTREPID project actively contributes to the treatment of phobias in an unobtrusive, personalized and intelligent manner.

INTREPID will serve to empower Community citizens in the management of their individual health, to provide health care professionals and facilities with a reliable phobias treatment and decision support tool and to create new opportunities for the medical wearable device industry. INTREPID will build upon the well documented increasing demand for "healthy lifestyle" products and services on the consumer side and offer potentially significant returns for those who chose to invest in the project outcome.

The INTREPID project scientific objectives are:

  • To effectively exploit the synergy in the information acquired from the various biometric sensors and develop new and efficient data fusion techniques, which will significantly broaden machine perception and enhance awareness of the phobia's states.
  • To create an identification system of the physiological and phobia-based emotional state of a patient (phobia's state) that will be based on the association of the information coming from the various biometric sensors.
  • To create a decision-making system that will project the current patient's phobia state into the future and draw inferences about the actions that should be taken in order to keep the patient in the desired phobia's state.
  • To create a new centralised sensor management system that will use active and selective perception techniques in order to optimize the overall performance of the identification system and the tracking system.
  • To create a powerful, intelligent and innovative humancomputer interaction environment that will boost the research and work on affective wearable computing and machine emotional intelligence domain.

The INTREPID project technological objectives are:

  • To create an advanced tracking system that will optimally monitor the symptoms of phobias. The system will measure heart rate, perspiration rate, breath rate, muscle stiffness and if needed complementary modalities through a set of miniaturized wearable sensors that the patient wears during the treatment session.
  • To create a sophisticated environment in a commercial wearable computer that will consist of:
  • To create a professional site for psychologists and therapists that will assist them to design the next steps of the patient's therapy taking into account the individualized physiological and emotional state of each patient.

For further information, please visit:
http://www.intrepid-project.org

Project co-ordinator:
Manchester University (UK)

Partners:

  • UNIMAN (UK)
  • ESIEA (FR)
  • AURELIA MICRO (IT)
  • UoI (EL)
  • PALADION (EL)
  • Elyros (BE)
  • InFocus (UK)

Timetable: from 01/04 to 12/06

Total cost: € 3,228,334

EC funding: € 2,000,000

Instrument: STREP

Project Identifier: IST-2002-507464

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...